MedPath

Effect of weight loss on improvement of liver inflammation and fibrosis in non- alcoholic fatty liver patients through calorie restricted diet

Not Applicable
Conditions
on-Alcoholic Fatty Liver - Non -Alcoholic Steatohepatitis.
Other specified inflammatory liver diseases
Registration Number
IRCT2017081535707N1
Lead Sponsor
Vice Chancellor for research of Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

1. BMI 25-40? Hepatic fibrosis 2 and higher? Liver enzymes 1.5 times more natural
Exclusion criteria: Viral hepatitis B, c ? Liver Cancer? alcohol consumption? Pregnancy ? Hepatic autoimmune diseases? Taking hepatotoxic drugs? Taking vitamin D supplement pills ? Patient's denial? Failure to observe the diet

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cytokeratin 18. Timepoint: First, 3 and 6 months after intervention. Method of measurement: ELIZA Kit.;Liver dysfunction factors. Timepoint: First.3 and 6 months after intervention. Method of measurement: Biochemistry Lab.
Secondary Outcome Measures
NameTimeMethod
iver Fibrosis. Timepoint: First,6 months after intervention. Method of measurement: Fibroscan Of liver.;Anthropometric measurements. Timepoint: first, 3 and 6 months after the intervention. Method of measurement: BIA device. Measuring body size with meter.
© Copyright 2025. All Rights Reserved by MedPath